BlasTaq™ DNA Polymerase
Cat. No. | G894 | ||||||||||
Name | BlasTaq™ DNA Polymerase | ||||||||||
Unit | 400 rxn | ||||||||||
Category | PCR Polymerase | ||||||||||
Description |
(Equivalent to Cat. No. G012, G040, G277, and G278.) Blast through a routine 2 hour PCR run in only 20 minutes!BlasTaq™ DNA Polymerase is a strategically-engineered, next generation Taq Polymerase that has rapid extension rates and robust performance. With specialized reaction conditions, this polymerase provides increased processivity, yields, and sensitivity, while shortening reaction times by up to 70%, compared to wild-type Taq DNA polymerase. BlasTaq™ has 5’-3’ polymerase and 5’-3’ exonuclease activities, lacks 3’-5’ exonuclease activity, and produces 3’-dA-tailed amplicons. PCR products made with BlasTaq™ can be used with TA cloning vectors. Product Features:
1Buffer contains 1.5 mm Mg2+.
|
||||||||||
Storage Condition |
Store at -20°C. This product is stable for 2 years from the date of shipping if stored and handled properly. |
||||||||||
Material Citation | If use of this material results in a scientific publication, please cite the material in the following manner: Applied Biological Materials Inc, Cat. No. G894 |
I am observing positive results in my negative controls (no template added) when attempting to detect gene sequences in a bacterial strain. I suspect this may be due to residual bacterial DNA from the DNA polymerase. What steps should I take to address this issue? | |
The presence of residual bacterial DNA is quite common in commercially available DNA polymerases, as most are expressed and purified using E. coli recombinant systems. In this case, we recommend switching to our Ultra-Pure BlasTaq™ 2X PCR MasterMix (Cat. No. G885). This product undergoes a rigorous multi-step purification protocol utilizing physical, chemical, and enzymatic methods to maximize the removal of contaminating genomic DNA.
|
- Yang, S., Tian, M., & Johnson, A. N. (2020). SARS-CoV-2 protein ORF3a is pathogenic inDrosophilaand causes phenotypes associated with COVID-19 post-viral syndrome. SARS-CoV-2 Protein ORF3a Is Pathogenic in Drosophila and Causes Phenotypes Associated with COVID-19 Post-Viral Syndrome. Published. DOI:10.1101/2020.12.20.423533